相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
Rachel N. Grisham et al.
CANCER (2013)
Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?
Nelly Auersperg
GYNECOLOGIC ONCOLOGY (2013)
Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
Russell Vang et al.
HISTOPATHOLOGY (2013)
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors
Alon D. Altman et al.
MODERN PATHOLOGY (2013)
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
John Farley et al.
LANCET ONCOLOGY (2013)
Ovarian low-grade serous carcinoma: A comprehensive update
Ivan Diaz-Padilla et al.
GYNECOLOGIC ONCOLOGY (2012)
Low-grade serous carcinomas of the ovary contain very few point mutations
Sian Jones et al.
JOURNAL OF PATHOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Risk factors for recurrence of ovarian borderline tumors
K. K. Shih et al.
GYNECOLOGIC ONCOLOGY (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
Data mining using the Catalogue of Somatic Mutations in Cancer BioMart
Rebecca Shepherd et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2011)
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis
Ie-Ming Shih et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
Kwong-Kwok Wong et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The pathology of and controversial aspects of ovarian borderline tumours
W. Glenn McCluggage
CURRENT OPINION IN ONCOLOGY (2010)
Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
Russell Vang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
Kuan-Ting Kuo et al.
CANCER RESEARCH (2009)
COLD-PCR-Enhanced High-Resolution Melting Enables Rapid and Selective Identification of Low-Level Unknown Mutations
Coren A. Milbury et al.
CLINICAL CHEMISTRY (2009)
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
Celestine S. Tung et al.
MODERN PATHOLOGY (2009)
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
Massimiliano Monticone et al.
MOLECULAR CANCER (2008)
The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma - A morphogic and molecular genetic analysis
Reiko Dehari et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma
Hyun S. Shvartsman et al.
GYNECOLOGIC ONCOLOGY (2007)
The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary
Kwong-Kwok Wong et al.
DISEASE MARKERS (2007)
KRAS and BRAF mutations in ovarian tumors:: A comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
Doris Mayr et al.
GYNECOLOGIC ONCOLOGY (2006)
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent
Elvio G. Silva et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Borderline ovarian tumors: Current concepts for prognostic factors and clinical management
Monica Brown Jones
CLINICAL OBSTETRICS AND GYNECOLOGY (2006)
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
Roman K. Thomas et al.
NATURE MEDICINE (2006)
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
T Bonome et al.
CANCER RESEARCH (2005)
Molecular pathogenesis of ovarian borderline tumors: New insights and old challenges
IM Shih et al.
CLINICAL CANCER RESEARCH (2005)
Ovarian serous tumors of low malignant potential (Borderline tumors) -: Outcome-based study of 276 patients with long-term (≥ 5-year) follow-up
TA Longacre et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas
CY Hsu et al.
CLINICAL CANCER RESEARCH (2004)
Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: A report of two cases
RL Parker et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Advanced-stage serous borderline tumors of the ovary: A clinicopathological study of 49 cases
CB Gilks et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential
MA Crispens et al.
OBSTETRICS AND GYNECOLOGY (2002)
Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations
F Al-Mulla et al.
JOURNAL OF PATHOLOGY (2001)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
